by Endobronchial ultrasound biopsy (EBUS) is a minimally invasive medical procedure that helps in the diagnosis and staging of lung cancer and other lung diseases. EBUS assists in obtaining samples from the lung and nearby lymph nodes through the use of an ultrasound bronchoscope. Inserted through the mouth or nose, the bronchoscope contains an ultrasound probe at its tip to guide aspiration needles for sampling lymph nodes and lung lesions. It provides real-time images to help physicians pinpoint abnormal areas for biopsy. EBUS has largely replaced surgical procedures for sampling mediastinal lymph nodes as it is safer, better tolerated, and highly accurate.
The global Endobronchial Ultrasound Biopsy Market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Growing prevalence of lung cancer cases: The prevalence of lung cancer cases globally is rising at an alarming rate. According to the World Health Organization, lung cancer is the most common type of cancer affecting over 2.1 million patients annually worldwide. Endobronchial ultrasound biopsy plays a vital diagnostic role in lung cancer staging and treatment planning. Thus, growing lung cancer burden is expected to drive higher adoption of EBUS procedures over the forecast period.
Real-time guidance improves biopsy accuracy: Compared to conventional bronchoscopy, EBUS offers real-time ultrasound guidance to help physicians precisely target abnormal lymph nodes or lesions for biopsy sampling. This improves the diagnostic accuracy of biopsy and reduces the need for repeat procedures. Higher accuracy of EBUS is boosting its popularity among healthcare providers for minimally invasive sampling of mediastinal structures.
Segment Analysis
The Endobronchial Ultrasound Biopsy Market Share is segmented by product into endobronchial ultrasound aspiration needles and endobronchial ultrasound biopsy forceps. Of these, the endobronchial ultrasound biopsy forceps segment is dominating currently constituting around 55% share of the overall market. Their ability to extract larger tissue samples compared to aspiration needles as well allows for clear diagnosis has helped them gain widespread acceptance among healthcare professionals.
PEST Analysis
Political: Healthcare regulations across major nations support use of minimally invasive procedures for lung cancer diagnosis and staging which has boosted adoption of endobronchial ultrasound biopsy systems.
Economic: Rising healthcare spending globally coupled with growing incidence of lung cancer has increased demand for advanced imaging systems like endobronchial ultrasound biopsy.
Social: Improved awareness among patients about early diagnosis benefits for lung cancer has raised acceptance for procedures like endobronchial ultrasound biopsy.
Technological: Continuous introduction of new features like image enhancement, elastography, navigation abilities in endobronchial ultrasound biopsy systems aid medical professionals with more accurate diagnosis.
Key Takeaways
The global endobronchial ultrasound biopsy market is expected to witness high growth.
Regional analysis: The Asia Pacific region is expected to witness the fastest growth in the endobronchial ultrasound biopsy market during the forecast period due to growing incidence of lung cancer, developing healthcare infrastructure and rising medical tourism in the region.
Key players operating in the endobronchial ultrasound biopsy market are Alf Engineering, F-TECH, Magna International, Metalsa, Nissin Kogyo, Sango Co., Ltd., Tata Precision Tubes, Tenneco, Thyssenkrupp AG, Vari-Form, and Yorozu.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
